BioCentury | Sep 7, 2018
Financial News

SCM raises $35M series C for stem cells to treat inflammation

...advance its pipeline of disease-specific mesenchymal stem cell therapies. Seoul-based investors DS Asset Management and Neoplux...
BioCentury | Jan 19, 2015
Financial News

Obalon Therapeutics completes venture financing

...financing Raised: $20 million Investors: Axon Ventures; Bader Sultan & Bros.; Mirae Asset Venture Investment; NeoPlux...
Items per page:
1 - 2 of 2
BioCentury | Sep 7, 2018
Financial News

SCM raises $35M series C for stem cells to treat inflammation

...advance its pipeline of disease-specific mesenchymal stem cell therapies. Seoul-based investors DS Asset Management and Neoplux...
BioCentury | Jan 19, 2015
Financial News

Obalon Therapeutics completes venture financing

...financing Raised: $20 million Investors: Axon Ventures; Bader Sultan & Bros.; Mirae Asset Venture Investment; NeoPlux...
Items per page:
1 - 2 of 2